Title |
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
|
---|---|
Published in |
Trials, June 2020
|
DOI | 10.1186/s13063-020-04380-5 |
Pubmed ID | |
Authors |
Qingsong Ye, Hua Wang, Xia Xia, Chenliang Zhou, Zhiming Liu, Zun-en Xia, Zhan Zhang, Yang Zhao, Jun Yehenala, Si Wang, Gangqiao Zhou, Ke Hu, Bin Wu, Chu-Tse Wu, Songling Wang, Yan He |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 737 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 737 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 86 | 12% |
Student > Master | 84 | 11% |
Researcher | 53 | 7% |
Other | 42 | 6% |
Student > Ph. D. Student | 42 | 6% |
Other | 134 | 18% |
Unknown | 296 | 40% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 197 | 27% |
Nursing and Health Professions | 68 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 22 | 3% |
Biochemistry, Genetics and Molecular Biology | 17 | 2% |
Immunology and Microbiology | 14 | 2% |
Other | 104 | 14% |
Unknown | 315 | 43% |